No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
TEVA240719P17500
- 0.42
- -0.16-27.59%
15min DelayClose Jul 12 15:59 ET
0.44High0.42Low
0.44Open0.58Pre Close4 Volume30 Open Interest17.50Strike Price174.00Turnover36.87%IV1.16%PremiumJul 19, 2024Expiry Date0.22Intrinsic Value100Multiplier4DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type-0.6041Delta0.5288Gamma42.15Leverage Ratio-0.0294Theta-0.0013Rho-25.46Eff Leverage0.0076Vega
Intraday
- 5D
- Daily
News
Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $20
Piper Sandler analyst David Amsellem maintains $Teva Pharmaceutical Industries(TEVA.US)$ with a buy rating, and maintains the target price at $20.According to TipRanks data, the analyst has a
UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $24
UBS analyst Ashwani Verma maintains $Teva Pharmaceutical Industries(TEVA.US)$ with a buy rating, and maintains the target price at $24.According to TipRanks data, the analyst has a success rate of 47.
Express News | Teva Pharmaceuticals : UBS Raises Target Price to $24 From $22
Express News | UBS Maintains Buy on Teva Pharmaceutical Indus, Raises Price Target to $24
Teva Pharmaceutical Indus Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/10/2024 41.26% UBS $22 → $24 Maintains Buy 06/27/2024 35.37% Jefferies $19 → $23 Maintains Buy 06/05/20
Argus Upgrades Teva to Buy, Cites Recent Drug Approvals
Comments
$Teva Pharmaceutical Industries(TEVA.US$ better than anticipated revenue growth 📈
MAYDAY!!!
🤣 hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫. I feel gu...
🤣 hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫. I feel gu...
loading...
21
4
its not bad if you hold it. it's just not my thing. too many swaps and derivatives for my liking.
$Teva Pharmaceutical Industries(TEVA.US$ & alvotechpr
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
3
1
$Teva Pharmaceutical Industries(TEVA.US$ Pray Kwan Yin bless teva
Read more